Author

Vasileios Tsatlidis

Observed name: VASILEIOS TSATLIDIS

Institutions: Gateshead Health NHS Foundation Trust, Queen Elizabeth Hospital

Observed institutions: University of Hull, Gateshead Health NHS Foundation Trust, Queen Elizabeth Hospital, Newcastle University

ORCID: 0000-0001-9413-5130

Observed ORCID: 0000-0001-9413-5130

OpenAlex ID: A5010219403

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial

2022 · Solomon Tesfaye, Gordon Sloan, et al. · The Lancet · 242

Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease

2018 · Arjola Bano, Earn Gan, et al. · The Journal of Clinical Endocrinology & Metabolism · 37

The GLP‐1 receptor agonist exenatide reduces serum TSH by its effect on body weight in people with type 2 diabetes

2023 · Su Ann Tee, Vasileios Tsatlidis, et al. · Clinical Endocrinology · 24

The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds

2016 · Sviatlana Zhyzhneuskaya, Caroline Addison, et al. · Thyroid · 22

Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT

2022 · Solomon Tesfaye, Gordon Sloan, et al. · Health Technology Assessment · 20

Cigarette smoking exposure and clinical outcomes in Graves' disease

2026 · Sarah Forbes, May Loo, et al. · The Journal of Clinical Endocrinology & Metabolism · 4

The prevalence and significance of nonuniform thyroid radio‐isotope uptake in patients with Graves’ disease

2022 · Altayeb Abdalaziz, Ramesh Vanka, et al. · Clinical Endocrinology · 4

Shorter Versus Standard Antithyroid Drug Therapy in Graves’ Disease with Lower Baseline Thyrotropin Receptor Antibody (TRAb) Levels: Relapse Outcomes from a Propensity-Weighted Analysis

2026 · Salman Razvi, Mia Holley, et al. · Thyroid · 1

The natural history of subclinical hyperthyroidism due to Graves' disease

2015 · Sviatlana Zhyzhneuskaya, Caroline Addison, et al. · Endocrine Abstracts · 1

Spontaneous normalisation of thyroid hormones in Graves' hyperthyroidism

2026 · Sophie Langdon, May Loo, et al. · Endocrine Abstracts

90-OR: FreeStyle Libre (FSL) Time in Range (TIR) and Time Below Range (TBR) : Impact on HbA1c, Diabetes-Related Distress (DRD) , and Resource Utilisation in the Association of British Clinical Diabetologists (ABCD) National Audit

2022 · HARSHAL DESHMUKH, BEATRICE PIERI, et al. · Diabetes

Copeptin during hypertonic saline infusion in a polyuria/polydipsia syndrome case series

2017 · Christopher Boot, R Andrew James, et al. · Endocrine Abstracts

The relationship between free T4 and thyrotropin receptor antibodies is log-linear and negatively influenced by age and smoking in patients with Graves' disease

2017 · Earn H Gan, Vasileios Tsatlidis, et al. · Endocrine Abstracts

Aberrant adrenal LH receptors leading to subclinical Cushing's syndrome: long-term effect of medical treatment with leuprolide acetate

2010 · Theodora Stratigou, Vasileios Tsatlidis, et al.

Works count: 14

Citation count: 351

H-index: 5

I10-index: 5